Palliative Care in Pancreatic Cancer

Cancer Control

Volumn 11, Issue 1, 2004, Pages 39-45

  Brescia, Frank J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIA; BILE DUCT OBSTRUCTION; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; DEPRESSION; DYING; FAMILY; FATIGUE; HUMAN; INTESTINE OBSTRUCTION; MEDICAL DECISION MAKING; PANCREAS CANCER; PROGNOSIS; REVIEW; SURVIVAL RATE;

EID: 2342517240     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100106     Document Type: Review

References (51)

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. Compton CC, Mulvihill SJ. Prognostic factors in pancreatic carcinoma. Surg Oncol Clin N Am. 1997;6:533-554.
3. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiology study. Br J Surg. 1995;82:111-115.
4. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg. 1995;221:721-733.
5. Winn RJ. Obstacles to the accrual of patients to clinical trials in the community setting. Semin Oncol. 1994(4 suppl 7);21:112-117.
6. Slevins ML. Making decisions about palliative chemotherapy. In: ASCO Educational Book. 1992.
7. Braverman AS. Medical oncology in the 1990s. Lancet. 1991;337:901-902.
8. Klastersky J. Supportive care: what for? Curr Opin Oncol. 1995;7:303.
9. Markman M. Introduction: treatment of malignancies poorly responsive to currently available antineoplastic therapy. Semin Oncol. 1994;21(4 suppl 7):1-2.
10. Bailes JS. Cost aspects of palliative cancer care. Semin Oncol. 1995;22(2 suppl 3):64-66.
11. Cherny N, Coyle N, Foley KM. Guidelines in the care of the dying cancer patient. Hematol Oncol Clin North Am. 1996;10:261-286.
12. McCrary SV, Swanson JW, Youngner SJ, et al. Physicians' quantitative assessments of medical futility. J Clin Ethics. 1994;5:100-105.
13. Sox HC Jr, Blatt MA, Higgins MC, et al, eds. Medical Decision-Making. Boston, Mass: Butterworth-Heinemann; 1988.
14. Daugherty CK. The "cure" for cancer: can the media report the hope without the hype? J Clin Oncol. 2002;20:3761-3764.
15. Meyers FJ, Linder J. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol. 2003;21:1412-1415.
16. Pearlman RA. Inaccurate predictions of life expectancy. Dilemmas and opportunities. Arch Intern Med. 1988;148:2537-2538.
17. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer. 1990;62:695-699.
18. Schonwetter RS, Teasdale TA, Storey P, et al. Estimation of survival time in terminal cancer patients: an impedance to hospice admissions? Hosp J. 1990;6:65-79.
19. DelVecchio Good MJ, Good BJ, Schaffer C, et al. American oncology and the discourse on hope. Cult Med Psychiatry. 1990;14:59-79.
20. Kodish E, Post SG. Oncology and hope. J Clin Oncol. 1995;13:1817.
21. Lamont EB, Christakis NA. Some elements of prognosis in terminal cancer. Oncology (Huntington). 1999;13:1165-1180.
22. Christakis NA. Death Foretold: Prophecy and Prognosis in Medical Care. Chicago, Ill: University of Chicago Press; 1999.
23. Emanuel EJ, Emanuel LL. The promise of a good death. Lancet. 1998;351(suppl 2):SII21-SII29.
24. Field MJ, Cassel CK, eds. Approaching Death: Improving Care at the End of Life. Committee on Care at the End of Life, Division of Health Care Services, Institute of Medicine. Washington, DC: National Academy Press; 1997.
25. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA. 1995;274:1591-1598.
26. Grossman SA, Sheidler VR, Swedeen K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage. 1991;6:53-57.
27. el-Kamar FG, Grossbard ML, Kozuch PS. Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care. Oncologist. 2003;8:18-34.
28. Tarnasky PR, Cotton PB. Randomized trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. Gastrointest Endosc. 1995;42:103-104.
29. Lammer J, Hausegger KA, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996;201:167-172.
30. Fras I, Litin EM, Pearson JS. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intraabdominal neoplasms. Am J Psychiatry. 1967;123:1553-1562.
31. Joffe RT, Rubinow DR, Denicoff KD, et al. Depression and carcinoma of the pancreas. Gen Hosp Psychiatry. 1986;8:241-245.
32. Massie MJ, Holland JC. The cancer patient with pain: psychiatric complications and their management. Med Clin North Am. 1987;71:243-258.
33. Foley KM. Pain assessment and cancer pain syndromes. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. Oxford, New York: Oxford University Press; 1998.
34. Kelsen DP, Portenoy RK, Thaler HT, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol. 1995;13:748-755.
35. Angelino AF, Treisman GJ. Major depression and demoralization in cancer patients: diagnostic and treatment considerations. Support Care Cancer. 2001;9:344-349.
36. Shakin EJ, Holland J. Depression and pancreatic cancer. J Pain Symptom Manage. 1988;3:194-198.
37. Brescia FJ, Portenoy RK, Ryan M, et al. Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol. 1992;10:149-155.
38. Solomon MZ, O'Donnell L, Jennings B, et al. Decisions near the end of life: professional views on life-sustaining treatments. Am J Public Health. 1993;83:14-23.
39. Levin DN, Cleeland CS, Dar R. Public attitudes toward cancer pain. Cancer. 1985;56:2337-2339.
40. Saunders C. Appropriate treatment, appropriate death. In: Saunders DC, ed. The Management of Terminal Malignant Disease. London, Baltimore, Md: Edward Arnold; 1984.
41. Kawamata M, Ishitani K, Ishikawa K, et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain. 1996;64:597-602.
42. Seamans DP, Wong GY, Wilson JL. Interventional pain therapy for intractable abdominal cancer pain. J Clin Oncol. 2000;18:1598-1600.
43. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040-4049.
44. Davis MP, Nouneh C. Modern management of cancer-related intestinal obstruction. Curr Oncol Rep. 2000;2:343-350.
45. Philip J, Lickiss N, Grant PT, et al. Corticosteroids in the management of bowel obstruction on a gynecological oncology unit. Gynecol Oncol. 1999;74:68-73.
46. Mangili G, Franchi M, Mariani A et al. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol. 1996;61:345-348.
47. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med. 2001;344:1681-1687.
48. Miaskowski C, Portenoy RK. Update on the assessment and management of cancer-related fatigue. Principles and Practice of Supportive Oncology Updates. 1998;1:1-10.
49. Simon AM, Zittoun R. Fatigue in cancer patients. Curr Opin Oncol. 1999;11:244-249.
50. Dunlop RJ, Campbell CW. Cytokines and advanced cancer. J Pain Symptom Manage. 2000;20:214-232.
51. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;6:7-15.